Menopause

Two new studies address hormone therapy post-WHI

Published in Women's Health Weekly, December 26th, 2002

Hormone therapy (HT) is the subject of two studies in the December 2002 issue of Obstetrics & Gynecology: the Women's Contraceptive and Reproductive Experiences Study of the National Institute of Child Health and Human Development (NICHD), and a data analysis from the Heart and Estrogen/Progestin Replacement Study (HERS).

Results from this NICHD-funded study of 3823 postmenopausal women were consistent with the recent Women's Health Initiative study results on continuous combined HT (defined here as estrogen combined with 25-31 days per month of progestin use). Continuous combined HT was associated with an increased breast cancer risk among current users of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-12-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry